@Pseudoname1 MM always points to some negotiation so I don't...

@Pseudoname1 MM always points to some negotiation so I don't think you could hang your hat on that being the case.

She stated that BIT was sharing and talking with other participants in the biotech sector - that is a long way from being a negotiation by definition.

I do agree that BIT should be investigating the general antiviral sector as a potential future development - but that would require a new trial series directed at that need - which is real.

That also will require considerable funds which BIT does not currently have.

Glad your little daughter is doing well. That would have been traumatic.

Apologies - reply tab not working.